Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62052240 | chr16:90025135 | C/T | 1.26E-8 | 171 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs62052249 | chr16:90044191 | G/C | 1.26E-8 | 171 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs62052252 | chr16:90048379 | T/C | 1.26E-8 | 171 | 25.97 | 20.17 | 6.62 | KM Plot |
PCPG | rs62052255 | chr16:90054724 | A/G | 1.11E-8 | 172 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs62052660 | chr16:89847420 | T/A | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs62052661 | chr16:90151351 | G/A | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs62052710 | chr16:89854893 | C/T | 0.000174 | 176 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs62052711 | chr16:89855100 | C/A | 0.000174 | 176 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs62052712 | chr16:89856913 | C/T | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs62052714 | chr16:89857180 | T/C | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs62053701 | chr16:89860584 | G/A | 0.000166 | 176 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62053702 | chr16:89860688 | G/T | 0.000166 | 176 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62054224 | chr16:89892071 | C/T | 0.000198 | 172 | 26.22 | 20.28 | 36.37 | KM Plot |
PCPG | rs62054251 | chr16:89892080 | A/G | 0.000198 | 172 | 26.22 | 20.28 | 36.37 | KM Plot |
PCPG | rs62054252 | chr16:89896834 | G/A | 0.000207 | 171 | 25.87 | 21.5 | 36.37 | KM Plot |